GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7DZ8 | P13352 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | A8IFG7 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | P59777 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | P14225 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | A8IL32 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | A8JCL6 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | Q93WL4 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | Q9ZSJ4 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7DZ8 | Q93WE0 | State transition supercomplex PSI-LHCI-LHCII from the LhcbM1 lacking mutant of Chlamydomonas reinhardtii | |
7E17 | Q03405 | Structure of dimeric uPAR | |
7E1Z | P05023 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state | |
7E1Z | P05026 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state | |
7E1Z | P54710 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state | |
7E20 | P05023 | Cryo EM structure of a K+-bound Na+,K+-ATPase in the E2 state | |
7E20 | P05026 | Cryo EM structure of a K+-bound Na+,K+-ATPase in the E2 state | |
7E20 | P54710 | Cryo EM structure of a K+-bound Na+,K+-ATPase in the E2 state | |
7E21 | P05023 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
7E21 | P05026 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
7E21 | P54710 | Cryo EM structure of a Na+-bound Na+,K+-ATPase in the E1 state with ATP-gamma-S | |
7E23 | P0DTC2 | SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) | |
7E23 | 7E23 | SARS-CoV-2 spike in complex with the CA521 neutralizing antibody Fab (focused refinement on Fab-RBD) | |
7E29 | P0AEX9 | Crystal Structure of Saccharomyces cerevisiae Ioc4 PWWP domain fused with MBP | |
7E29 | Q04213 | Crystal Structure of Saccharomyces cerevisiae Ioc4 PWWP domain fused with MBP | |
7E2G | Q96F81 | Cryo-EM structure of hDisp1NNN-3C | |
7E2H | Q96F81 | Cryo-EM structure of hDisp1NNN-3C-Cleavage | |
7E2I | Q96F81 | Cryo-EM structure of hDisp1NNN-ShhN | |
7E2I | Q15465 | Cryo-EM structure of hDisp1NNN-ShhN | |
7E2V | 7E2V | Crystal structure of MaDA-3 | |
7E39 | P0DTC2 | SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) | |
7E39 | 7E39 | SARS-CoV-2 spike in complex with the Ab4 neutralizing antibody (State 3) | |
7E3B | P0DTC2 | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
7E3B | 7E3B | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
7E3C | P0DTC2 | SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) | |
7E3C | 7E3C | SARS-CoV-2 spike in complex with the Ab1 neutralizing antibody (focused refinement on Fab-RBD) | |
7E3D | P22303 | Crystal structure of human acetylcholinesterase | |
7E3E | D6XHE1 | Crystal structure of Trypanosoma brucei cathepsin B R91C/T223C mutant | |
7E3F | D6XHE1 | Crystal structure of Trypanosoma brucei cathepsin B Y217C/S275C mutant | |
7E3G | D6XHE1 | Crystal structure of Trypanosoma brucei cathepsin B R91C/T223C mutant in the living cell | |
7E3H | P22303 | Crystal structure of human acetylcholinesterase in complex with donepezil | |
7E3J | 7E3J | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
7E3J | P0DTC2 | Crystal structure of SARS-CoV-2 RBD binding to dog ACE2 | |
7E3K | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3K | 7E3K | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3L | P0DTC2 | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E3L | 7E3L | Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants | |
7E57 | Q7TS55 | Crystal structure of murine GITR-GITRL complex | |
7E57 | O35714 | Crystal structure of murine GITR-GITRL complex | |
7E5M | P09758 | crystal structure of trans assembled human TROP-2 | |
7E5O | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
7E5O | 7E5O | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024